Vice President, Head of Clinical Operations

North Tyneside, NE29 8EP, United Kingdom
Today
Job Type
Permanent
Work Pattern
Full-time
Work Location
On-site
Seniority
Director
Posted
3 Jun 2026 (Today)

Your work will change lives. Including your own.

The Impact You’ll Make

At Recursion, we are decoding biology to radically improve lives. As Vice President, Head of Clinical Operations, you will own clinical operations strategy and execution across Recursion’s development portfolio from study planning through study closeout, data delivery, inspection readiness, and registrational support.

This is a portfolio-wide leadership role for an experienced clinical operations leader who can build scalable operating models, lead high-performing teams, manage global trials, and ensure operational excellence across early and late-stage clinical programs. You will also help define what modern clinical operations look like in an AI-native TechBio company: data-driven, quality-focused, patient-centered, technology-enabled, and built to move with urgency because patients are waiting.

In this role, you will:

  • Lead clinical operations strategy and execution across Recursion’s full clinical portfolio, from IND/CTA planning and first-in-human studies through proof-of-concept, pivotal trials, study closeout, and submission support
  • Own end-to-end operational delivery, including study planning, feasibility, country and site strategy, start-up, enrollment, monitoring, vendor oversight, budget management, database lock readiness, and closeout
  • Build, scale, and mentor a high-performing Clinical Operations organization, including clinical project management, clinical trial management, outsourcing/vendor oversight, and portfolio operations capabilities
  • Establish portfolio-level governance, operating rhythms, KPIs, dashboards, risk management, resource planning, and escalation pathways to support timely, high-quality trial execution
  • Lead CRO and vendor strategy relationships, including outsourcing model, selection, contracting partnership, performance management, issue escalation, budget forecasting, and accountability for delivery
  • Ensure inspection-ready execution across all studies through strong GCP compliance, SOP adherence, TMF oversight, risk-based quality management, audit readiness, CAPA management, and proactive issue resolution

The Team You’ll Join

You will join Recursion’s Clinical Development organization, reporting to our Chief Medical Officer. The Clinical Development team is an empowered, execution-minded group responsible for translating Recursion’s innovative science into medicines for patients.

You will work closely with leaders across Development, Regulatory, Development Sciences, Clinical Operations, Data Science, Biology, Chemistry, Portfolio Strategy, Communications, Legal/Compliance, and future commercialization functions. Together, you will help ensure Recursion’s clinical programs are informed by robust evidence, external medical insight, patient need, and the full potential of the RecursionOS.

The Experience You’ll Need

  • Bachelor’s degree in a scientific, healthcare, or related field required; advanced degree preferred
  • 15+ years of biotech or pharmaceutical clinical operations experience, including significant leadership experience overseeing multiple clinical programs and global clinical trials
  • Proven track record leading clinical operations from early development through pivotal studies, registration-enabling trials, study closeout, and submission support
  • Deep experience with clinical trial planning and execution, including feasibility, start-up, enrollment, monitoring, vendor/CRO oversight, budget management, risk management, database lock, and closeout
  • Strong working knowledge of FDA, EMA, MHRA, ICH/GCP, global clinical trial regulations, quality systems, inspection readiness, and risk-based quality management
  • Experience building and leading teams, including leaders of clinical operations, clinical project managers, clinical trial managers, consultants, CRO partners, and functional vendors
  • Strong executive presence with the ability to communicate clearly, influence senior stakeholders, resolve complex operational issues, and drive decisions in a fast-moving environment
  • Experience in oncology, rare disease, and/or specialty clinical development preferred; experience with clinical trial technologies, CTMS/eTMF/EDC/IRT/eCOA, operational dashboards, automation, or AI-enabled workflows is a plus

Working Location & Compensation:

This is an office-based, hybrid position at our office located inNew York City, New York. Employees are expected to work in the office at least 50% of the time.

At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is$333,960 to $400,510 (USD). You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.

#LI-DB1

#LI-REMOTE

The Values We Hope You Share:

  • We act boldly with integrity.We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
  • We care deeply and engage directly.Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
  • We learn actively and adapt rapidly.Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
  • We move with urgency because patients are waiting.Speed isn’t about rushing but about moving the needle every day.
  • We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
  • We are One Recursion.True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.

More About Recursion

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.

Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.

Accommodations are available on request for candidates taking part in all aspects of the selection process.


Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.

Related Jobs

View all jobs
Spotlight

Senior Director, Global Clinical Program Lead, Immunoglobulin

CSL
Spotlight

Director Biostatistics - Hematology

CSL

Vice President, Head of Clinical Operations

Recursion United Kingdom
On-site

Vice President, Head of Strategy & Operations

Recursion North Tyneside, NE29 8EP, United Kingdom

Vice President, Head of IP and Strategic Transactions

Recursion United Kingdom
On-site

Vice President, Medical Affairs

Recursion North Tyneside, NE29 8EP, United Kingdom
On-site

Vice President, Real World Evidence (RWE)

Recursion United Kingdom

Vice President, Medical Affairs

Recursion United Kingdom
On-site

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Where to Advertise Biotech Jobs in the UK (2026 Guide)

Where to advertise biotech jobs UK in 2026: the specialist boards, academic networks and trade channels that reach biotech R&D and bioprocessing talent. The candidate pool spans life scientists, computational biologists, regulatory specialists and biomanufacturing engineers — each with distinct professional networks and job search behaviours. General job boards reach a broad audience but lack the specificity that biotech professionals expect. Specialist platforms, academic channels and sector-specific communities each serve a different part of the market. This guide, published by BiotechnologyJobs.co.uk, covers where to advertise biotech roles in the UK in 2026, how the main platforms compare, what employers should expect to pay, and what the data says about hiring across different role types.

Biotech Jobs UK 2026: What to Expect Over the Next 3 Years

Biotech Jobs UK 2026: roles, salaries and the genomics, cell therapy and AI-driven drug discovery hiring trends shaping UK biotech careers. Biotechnology is creating jobs at a rate that few other sectors can match. New disciplines are emerging from research labs and entering commercial hiring pipelines, existing roles are fragmenting into deeper specialisms, and the technologies driving it all — from AI-assisted drug discovery to next-generation gene editing — are advancing faster than the workforce can keep pace with. For job seekers, this creates an unusual challenge. In most industries, career planning means navigating a relatively familiar landscape and identifying where your skills fit. In biotech, that landscape is being actively redrawn. The roles generating the most hiring activity in 2028 may look quite different from the ones appearing in job adverts today. That's not a reason to feel overwhelmed — it's a reason to get informed. The candidates who thrive in this market aren't always those with the longest CVs or the most letters after their name. They're the ones who understand where the sector is heading: which disciplines are gaining commercial traction, which technologies are driving employer demand, and how the definition of a "biotech job" is expanding well beyond traditional pharmaceuticals and research roles. This article breaks down what the UK biotech jobs market is likely to look like over the next three years — covering emerging job titles, the technologies reshaping hiring, the skills employers are prioritising right now, and how to position your career ahead of the curve rather than behind it.